• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

增殖性糖尿病视网膜病变行全视网膜激光光凝术后视网膜病变危险因素的消退

Retinopathy risk factor regression after laser panretinal photocoagulation for proliferative diabetic retinopathy.

作者信息

Doft B H, Blankenship G

出版信息

Ophthalmology. 1984 Dec;91(12):1453-7. doi: 10.1016/s0161-6420(84)34123-9.

DOI:10.1016/s0161-6420(84)34123-9
PMID:6084215
Abstract

Fifty eyes of patients with proliferative diabetic retinopathy were followed at frequent intervals to determine the rapidity and stability of retinopathy risk factor regression after argon laser panretinal photocoagulation. Retinopathy risk factors regress rapidly after laser photocoagulation. The incidence of eyes at high risk for severe visual loss (eyes with 3 or more retinopathy risk factors) decreased from 100% prior to treatment to 28% three weeks after treatment. The early response to treatment was a good prognostic indicator of longer term results. Seventy-two percent of eyes which improved from a high- to a low-risk category by three weeks continued to remain at low risk at six months. Sixty-four percent of eyes which failed to improve to a low-risk category by three weeks continued to remain at high risk at six months. The early response to laser panretinal ablation may be used to predict longer-term results.

摘要

对50例增殖性糖尿病视网膜病变患者的眼睛进行了定期随访,以确定氩激光全视网膜光凝术后视网膜病变危险因素消退的速度和稳定性。激光光凝术后视网膜病变危险因素迅速消退。严重视力丧失高危眼(有3个或更多视网膜病变危险因素的眼睛)的发生率从治疗前的100%降至治疗后3周的28%。治疗的早期反应是长期结果的良好预后指标。在3周时从高危类别改善为低危类别的眼睛中,72%在6个月时仍保持低危状态。在3周时未能改善为低危类别的眼睛中,64%在6个月时仍处于高危状态。氩激光全视网膜光凝的早期反应可用于预测长期结果。

相似文献

1
Retinopathy risk factor regression after laser panretinal photocoagulation for proliferative diabetic retinopathy.增殖性糖尿病视网膜病变行全视网膜激光光凝术后视网膜病变危险因素的消退
Ophthalmology. 1984 Dec;91(12):1453-7. doi: 10.1016/s0161-6420(84)34123-9.
2
Xenon arc photocoagulation of proliferative diabetic retinopathy. A review of 2688 consecutive eyes in the format of the Diabetic Retinopathy Study.增殖性糖尿病视网膜病变的氙弧光凝术。以糖尿病视网膜病变研究的形式对2688只连续眼进行的回顾。
Ophthalmology. 1984 Dec;91(12):1458-63. doi: 10.1016/s0161-6420(84)34122-7.
3
Incremental panretinal photocoagulation. Results in treating proliferative diabetic retinopathy.递增式全视网膜光凝术。治疗增殖性糖尿病视网膜病变的结果。
Retina. 1983 Fall-Winter;3(4):308-11. doi: 10.1097/00006982-198300340-00015.
4
Treatment of proliferative diabetic retinopathy with panretinal cryotherapy.全视网膜冷冻疗法治疗增殖性糖尿病视网膜病变
Ophthalmic Surg. 1984 Sep;15(9):741-5.
5
Red krypton and blue-green argon panretinal laser photocoagulation for proliferative diabetic retinopathy: a laboratory and clinical comparison.用于增殖性糖尿病视网膜病变的红色氪和蓝绿色氩全视网膜激光光凝术:一项实验室与临床比较研究
Trans Am Ophthalmol Soc. 1986;84:967-1003.
6
Altered retinal vascular response to 100% oxygen breathing in diabetes mellitus.糖尿病患者视网膜血管对吸入100%氧气的反应改变。
Ophthalmology. 1984 Dec;91(12):1447-52. doi: 10.1016/s0161-6420(84)34124-0.
7
"Early" vitrectomy for vasoproliferative retinopathy in patients with insulin-dependent diabetes mellitus.胰岛素依赖型糖尿病患者增殖性视网膜病变的“早期”玻璃体切除术
Can J Ophthalmol. 1982 Aug;17(4):150-2.
8
A clinical comparison of central and peripheral argon laser panretinal photocoagulation for proliferative diabetic retinopathy.增殖性糖尿病视网膜病变的中心和周边氩激光全视网膜光凝术的临床比较
Ophthalmology. 1988 Feb;95(2):170-7. doi: 10.1016/s0161-6420(88)33212-4.
9
Treatment of proliferative diabetic retinopathy. Long-term results of argon laser photocoagulation.
Ophthalmology. 1985 Feb;92(2):279-83. doi: 10.1016/s0161-6420(85)34059-9.
10
Augmentation laser for proliferative diabetic retinopathy that fails to respond to initial panretinal photocoagulation.用于对初始全视网膜光凝无反应的增殖性糖尿病视网膜病变的强化激光治疗。
Ophthalmology. 1992 Nov;99(11):1728-34; discussion 1734-5. doi: 10.1016/s0161-6420(92)31739-7.

引用本文的文献

1
The progress of assessment methods and treatments of neovascular glaucoma secondary to central retinal vein occlusion.视网膜中央静脉阻塞继发新生血管性青光眼的评估方法与治疗进展
Front Med (Lausanne). 2024 Jan 8;10:1280776. doi: 10.3389/fmed.2023.1280776. eCollection 2023.
2
Anti-vascular endothelial growth factor for neovascular glaucoma.抗血管内皮生长因子治疗新生血管性青光眼。
Cochrane Database Syst Rev. 2023 Apr 3;4(4):CD007920. doi: 10.1002/14651858.CD007920.pub4.
3
Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.
增生性糖尿病性视网膜病变在糖尿病性视网膜病变患者中发展和进展的预测因素。
Cochrane Database Syst Rev. 2023 Feb 22;2(2):CD013775. doi: 10.1002/14651858.CD013775.pub2.
4
Anti-vascular endothelial growth factor for neovascular glaucoma.抗血管内皮生长因子治疗新生血管性青光眼
Cochrane Database Syst Rev. 2020 Feb 6;2(2):CD007920. doi: 10.1002/14651858.CD007920.pub3.
5
Timing of neovascular regression in eyes with high-risk proliferative diabetic retinopathy without macular edema treated initially with intravitreous bevacizumab.最初接受玻璃体内注射贝伐单抗治疗的无黄斑水肿的高危增殖性糖尿病视网膜病变患者眼内新生血管消退的时间
Clin Ophthalmol. 2018 Dec 19;13:27-31. doi: 10.2147/OPTH.S182420. eCollection 2019.
6
Efficacy and Safety of Intracameral Bevacizumab for Treatment of Neovascular Glaucoma.前房内注射贝伐单抗治疗新生血管性青光眼的疗效与安全性
Korean J Ophthalmol. 2017 Dec;31(6):538-547. doi: 10.3341/kjo.2017.0017. Epub 2017 Oct 20.
7
Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab.玻璃体腔注射贝伐单抗治疗与未治疗新生血管性青光眼的长期预后
Eye (Lond). 2016 Mar;30(3):463-72. doi: 10.1038/eye.2015.259. Epub 2015 Dec 18.
8
Modern retinal laser therapy.现代视网膜激光治疗
Saudi J Ophthalmol. 2015 Apr-Jun;29(2):137-46. doi: 10.1016/j.sjopt.2014.09.001. Epub 2014 Sep 28.
9
Multimodal characterization of proliferative diabetic retinopathy reveals alterations in outer retinal function and structure.增殖性糖尿病视网膜病变的多模态特征揭示了视网膜外层功能和结构的改变。
Ophthalmology. 2015 May;122(5):957-67. doi: 10.1016/j.ophtha.2014.12.001. Epub 2015 Jan 17.
10
Triamcinolone and bevacizumab as adjunctive therapies to panretinal photocoagulation for proliferative diabetic retinopathy.曲安奈德和贝伐单抗作为增殖性糖尿病视网膜病变全视网膜光凝的辅助治疗方法。
ISRN Ophthalmol. 2012 Oct 15;2012:267643. doi: 10.5402/2012/267643. eCollection 2012.